The Immunosuppressive Microenvironment of Glioblastoma: Mechanisms, Clinical Challenges and Future Directions
Immunology · 2026-04 · 177 (4) · 662-673
DOI: 10.1111/imm.70087 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Immunology, online erschienen am 19.12.2025. Verfasst von Changming Pang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Hainan Key Laboratory for Research and Development of Tropical Herbs, Haikou Key Laboratory of Li Nationality Medicine, School of Pharmacy, Engineeri…. Hauptthemen laut MEDLINE: Glioblastoma, Tumor Microenvironment, Brain Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 97 Literaturangaben. Gefördert von: Hainan Province Science and Technology Special Fund, Academic Enhancement Support Program of Hainan Medical University, National Innovation and Entrepreneurship Training Program for Undergraduate.
Abstract (Originalsprache)
Glioblastoma (GBM) remains highly lethal due to intrinsic and extrinsic mechanisms, of which the immunosuppressive tumour microenvironment (TME) collectively limits treatment efficacy. This review synthesises recent advances in understanding how metabolic reprogramming, epigenetic remodelling and immune cell dysfunction converge to establish a stable immunosuppressive network dominated by tumour‐associated macrophages (TAMs), myeloid‐derived suppressor cells (MDSCs), regulatory T cells and exhausted T cells. We further summarise emerging therapeutic strategies, including myeloid‐targeting agents, epigenetic modulators, metabolic inhibitors and combination immunotherapy, and discuss their clinical potential in overcoming GBM immune resistance. These insights provide a mechanistic and translational framework for developing next‐generation multimodal treatment approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hainan Key Laboratory for Research and Development of Tropical Herbs, Haikou Key Laboratory of Li Nationality Medicine, School of Pharmacy, Engineering Research Center of Tropical Medicine Innovation and Transformation…
- Hainan Academy of Medical Sciences, Hainan Medical University, Haikou, China.
ORCID-Profile: Changming Pang
Förderung
- Hainan Province Science and Technology Special Fund
- Academic Enhancement Support Program of Hainan Medical University
- National Innovation and Entrepreneurship Training Program for Undergraduate
- National College Students Innovation and Entrepreneurship Training Program
Zitieren
APA
Pang, C., & Wang, Y. (2026). The Immunosuppressive Microenvironment of Glioblastoma: Mechanisms, Clinical Challenges and Future Directions. Immunology, 177(4), 662-673. https://doi.org/10.1111/imm.70087
Vancouver
Pang C, Wang Y. The Immunosuppressive Microenvironment of Glioblastoma: Mechanisms, Clinical Challenges and Future Directions. Immunology. 2026;177(4):662-673. doi:10.1111/imm.70087
BibTeX
@article{Pang2026,
author = {Pang, Changming and Wang, Yan},
title = {The Immunosuppressive Microenvironment of Glioblastoma: Mechanisms, Clinical Challenges and Future Directions},
journal = {Immunology},
year = {2026},
volume = {177},
number = {4},
pages = {662--673},
doi = {10.1111/imm.70087}
}
EUVIMED